Locations:
Search IconSearch
April 12, 2019/Cancer

Good QOL Outcomes Achieved After Extended Bifrontal Resection for Giant Meningiomas

Pilot study supports routine neuropsychological testing before and after the surgery

Patients who underwent an extended bifrontal approach for resection of a giant anterior cranial base meningioma had improved processing speed postoperatively and no significant changes in nine other neuropsychological quality-of-life (QOL) indicators in a Cleveland Clinic study presented at the 2019 annual meeting of the North American Skull Base Society.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Given the impairment we expect to see with frontal tumors, our findings suggest that the extended bifrontal approach may be an improvement over traditional surgery,” says Cleveland Clinic neurosurgeon Pablo Recinos, MD, senior author of the study. “Neuropsychological testing before and after brain surgery provided important information on quality-of-life parameters.”

Background: Given a good prognosis, QOL gains primacy

Meningiomas are the most common intracranial neoplasm, representing about 40% of cases. Fortunately, WHO grade I meningiomas tend to have a benign course, especially after surgical resection. Often, however, patients have neuropsychological deficits from the tumor, and little is documented about how patients may improve — or worsen — as a result of surgery.

“Traditionally, success in brain tumor treatment is defined by extent of resection, as well as morbidity and mortality after surgery,” says Cleveland Clinic research team member Alankrita Raghavan, who presented the study. “However, because many patients with a meningioma live for decades after treatment, neuropsychological outcomes become a critically important consideration when determining the best surgical approach.”

She adds that QOL outcomes are especially relevant for a giant anterior base meningioma (defined as > 4 cm) because patients usually have considerable cognitive impairment preoperatively. Moreover, the surgery itself is not without risk, especially for such large tumors. Traditional bifrontal craniotomies can require significant brain retraction: Cortical infarction is more likely to occur when retraction pressures are above 20 mmHg and are held for longer than 15 minutes.

Advertisement

Reported outcomes in the literature with traditional surgery include significant postoperative impairments in neuropsychological measures, such as executive function, verbal memory and information processing.

Study design and findings: Assessing extended bifrontal craniotomy

The Cleveland Clinic researchers hypothesized that an extended bifrontal craniotomy would improve neuropsychological outcomes compared with the traditional approach. As shown in the photos below, extended bifrontal craniotomy involves removal of the orbital bar, thereby offering a low trajectory to the base of the tumor, decreasing the need for retraction and reducing edema because of the increased exposure.

Extended bifrontal craniotomy is the removal of the orbital bar

This pilot study involved 16 patients (10 women, mean age 56.3 years, mean tumor diameter 5.78 cm) who underwent an extended bifrontal craniotomy at Cleveland Clinic from 2016 through 2018. Traditional surgical parameters were evaluated, with 10 patients also undergoing neuropsychological assessment, which was designed and directed by neuropsychologist and coinvestigator Richard Naugle, PhD, of Cleveland Clinic’s Center for Behavioral Health.

Six patients had matched pre- and postoperative neuropsychological testing. Preoperative testing was usually performed within a few days of surgery; postoperative testing times varied (median, 90 days postoperatively [range, 84-112]).

The most common presenting symptoms preoperatively were cognitive changes (56%), personality changes (50%), anosmia (37.5%), visual deficits (37.5%) and seizures (25%).

Results of before-and-after neuropsychological testing were as follows:

  • Five (of six) patients improved postoperatively in overall scores.
  • Processing speed significantly improved postoperatively.
  • Improvement in executive function trended toward significance (P = 0.054).
  • Semantic fluency and attention scores decreased postoperatively, although differences were not statistically significant.
  • Visuospatial memory, verbal memory, phonemic fluency, naming and manual dexterity improved postoperatively, although differences were not statistically significant.

Advertisement

A proposal for routine, efficient testing

In view of these findings, Dr. Recinos proposes assessing frontal lobe function in this patient population with a short battery of tests, consisting of:

  • Verbal memory: Hopkins Verbal Learning Test
  • Processing speed: Wechsler Adult Intelligence Scale-IV, coding task
  • Naming: Boston Naming Test (short form)
  • Phonemic fluency: Controlled Oral Word Association Test
  • Executive function: Stroop test, Trails A & B
  • Emotional distress: Beck Depression Inventory

Altogether, complete testing would take only about 40 minutes, he notes, while a standard battery of tests takes more than three times as long.

Dr. Recinos adds that the proposed tests are not the most challenging in each domain. If a patient performed particularly poorly in any area, further specific testing could be done to ascertain a more precise score.

“The results of our small study demonstrate the need for efficient and effective neuropsychological testing that can be routinely administered to evaluate standard and novel surgical approaches,” concludes Dr. Recinos. “Such testing could also help us inform patients which parameters can be expected to change after surgery and which areas may require postoperative rehabilitative therapy.”

Advertisement

Related Articles

genetic test
January 16, 2026/Cancer/News & Insight
Five Percent of U.S. Population Carries Pathogenic Variants Associated with Cancer Risk

Genetic variants exist irrespective of family history or other contributing factors

GLP-1
January 12, 2026/Cancer/Blood Cancers
GLP-1a Therapy Improves Survival in Patients with Polycythemia Vera and Myelodysplastic Syndromes

Study shows significantly reduced risk of mortality and disease complications in patients receiving GLP-1 agonists

Oncology nurse
January 9, 2026/Cancer
Improving Patient Experience in Inpatient Hematology: A Nursing Perspective

Structured interventions enhance sleep, safety and caregiver resiliency in high-acuity units

PET scan
January 7, 2026/Cancer/Blood Cancers
Case Study: 21-Year-Old Patient with Refractory T-Cell Lymphoma

Addressing rare disease and challenging treatment course in an active young patient

Dr. Angelini
December 24, 2025/Cancer/News & Insight
Study Analyzes Direct Oral Anticoagulants Use in Patients with Brain Metastases

Large retrospective study suggests DOACs are safe, effective alternative to low-molecular-weight heparin in complex patient population

Dr. Singh
December 19, 2025/Cancer/Blood Cancers
IDH1 Inhibitor Found Safe and Effective in Rare Precursor to Blood Malignancies

Study shows high rate of hematologic responses, low rate of disease progression

Shahzad Raza, MD
December 18, 2025/Cancer/Blood Cancers
Talquetamab Provides Lifesaving Bridge to CAR T-Cell Therapy

Bispecific antibody bridging therapy deepens durability of BCMA CAR T-cell therapy without overlapping toxicities in patients with relapsed/refractory multiple myeloma

Dr. Raza
December 16, 2025/Cancer/Blood Cancers
Dual Bispecifics May Redefine Management of Extramedullary Myeloma

Phase 2 study brings pivotal advances in treatment efficacy and safety for the most challenging-to-treat population

Ad